|
|
肠道中特异性菌群促进结直肠癌发生发展的研究进展
|
Abstract:
结直肠癌(colorectal cancer, CRC)是世界上常见的消化道恶性肿瘤，也是死亡率最高的癌症之一，且发病率呈现逐年上升的趋势。近年来基于测序技术和宏基因组学的大量研究显示，肠道菌群失调与CRC的发生发展具有密切联系。尤其是具核梭杆菌(Fusobacterium nucleatum, F. nucleatum)、产肠毒素脆弱拟杆菌(Enterotoxigenic Bacteroides fragilis, ETBF)、大肠杆菌(Escherichia coli, E. coli)等特异性菌群与CRC的发生紧密相关，因此本文结合国内外最新的研究进展，就这些特异性菌群可能的致癌作用机制作一综述，以期为未来CRC的诊断及治疗提供新的方向。
Colorectal cancer (CRC) is a common malignant tumor of the digestive tract in the world, and it is also one of the cancers with the highest mortality rate, and the incidence is increasing year by year. In recent years, a large number of studies based on sequencing technology and metagenomics have shown that intestinal flora imbalance is closely related to the occurrence and development of CRC. In particular, specific bacteria such as Fusobacterium nucleatum, enterotoxigenic Bacteroides fra-gilis and Escherichia coli are closely related to the occurrence of CRC. Therefore, this article reviews the possible carcinogenic mechanisms of these specific bacteria based on the latest research pro-gress at home and abroad, in order to provide new directions for the diagnosis and treatment of CRC in the future.
| [1] | Quaglio, A.E.V., Grillo, T.G., Oliveira, E.C.S.D., et al. (2022) Gut Microbiota, Inflammatory Bowel Disease and Colo-rectal Cancer. World Journal of Gastroenterology, 28, 4053-4060. https://doi.org/10.3748/wjg.v28.i30.4053 |
| [2] | Marchesi, J.R., Adams, D.H., Fava, F., et al. (2016) The Gut Mi-crobiota and Host Health: A New Clinical Frontier. Gut, 65, 330-339. https://doi.org/10.1136/gutjnl-2015-309990 |
| [3] | Wong, C.C. and Yu, J. (2023) Gut Microbiota in Colorectal Can-cer Development and Therapy. Nature Reviews Clinical Oncology, 20, 429-452. https://doi.org/10.1038/s41571-023-00766-x |
| [4] | Yachida, S., Mizutani, S., Shiroma, H., et al. (2019) Meta-genomic and Metabolomic Analyses Reveal Distinct Stage-Specific Phenotypes of the Gut Microbiota in Colorectal Can-cer. Nature Medicine, 25, 968-976.
https://doi.org/10.1038/s41591-019-0458-7 |
| [5] | Li, J., Zhu, Y., Yang, L., et al. (2022) Effect of Gut Microbiota in the Colorectal Cancer and Potential Target Therapy. Discover Oncology, 13, Article No. 51. https://doi.org/10.1007/s12672-022-00517-x |
| [6] | De Vos, W.M., Tilg, H., Van Hul, M., et al. (2022) Gut Micro-biome and Health: Mechanistic Insights. Gut, 71, 1020-1032. https://doi.org/10.1136/gutjnl-2021-326789 |
| [7] | Henne, K., Schilling, H., Stoneking, M., et al. (2018) Sex-Specific Differences in the Occurrence of Fusobacterium nucleatum Subspecies and Fusobacterium periodonticum in the Oral Cavity. Oncotarget, 9, 20631-20639.
https://doi.org/10.18632/oncotarget.25042 |
| [8] | Kostic, A.D., Gevers, D., Pedamallu, C.S., et al. (2012) Genomic Analysis Identifies Association of Fusobacterium with Colorectal Carcinoma. Genome Research, 22, 292-298. https://doi.org/10.1101/gr.126573.111 |
| [9] | Casasanta, M.A., Yoo, C.C., Udayasuryan, B., et al. (2020) Fusobac-terium nucleatum Host-Cell Binding and Invasion Induces IL-8 and CXCL1 Secretion That Drives Colorectal Cancer Cell Migration. Science Signaling, 13, eaba9157. |
| [10] | Beaugerie, L., Svrcek, M., Seksik, P., et al. (2013) Risk of Colo-rectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients with Inflammatory Bowel Disease. Gastroenterology, 145, 166-175.e8.
https://doi.org/10.1053/j.gastro.2013.03.044 |
| [11] | Kostic, A.D., Chun, E., Robertson, L., et al. (2013) Fusobacte-rium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host & Microbe, 14, 207-215.
https://doi.org/10.1016/j.chom.2013.07.007 |
| [12] | Proen？a, M.A., Biselli, J.M., Succi, M., et al. (2018) Relationship between Fusobacterium nucleatum, Inflammatory Mediators and microRNAs in Colorectal Carcinogenesis. World Journal of Gastroenterology, 24, 5351-5365.
https://doi.org/10.3748/wjg.v24.i47.5351 |
| [13] | Bashir, A., Miskeen, A.Y., Hazari, Y.M., et al. (2016) Fusobacte-rium nucleatum, Inflammation, and Immunity: The Fire within Human Gut. Tumor Biology, 37, 2805-2810. https://doi.org/10.1007/s13277-015-4724-0 |
| [14] | Gur, C., Ibrahim, Y., Isaacson, B., et al. (2015) Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell At-tack. Immunity, 42, 344-355.
https://doi.org/10.1016/j.immuni.2015.01.010 |
| [15] | Sun, C., Li, B., Wang, B., et al. (2019) The Role of Fusobacte-rium nucleatum in Colorectal Cancer: From Carcinogenesis to Clinical Management. Chronic Diseases and Translation-al Medicine, 5, 178-187.
https://doi.org/10.1016/j.cdtm.2019.09.001 |
| [16] | Sun, F., Zhang, Q., Zhao, J., et al. (2019) A Potential Species of Next-Generation Probiotics? The Dark and Light Sides of Bacteroides fragilis in Health. Food Research International, 126, Article ID: 108590.
https://doi.org/10.1016/j.foodres.2019.108590 |
| [17] | Si, H., Yang, Q., Hu, H., et al. (2021) Colorectal Cancer Oc-currence and Treatment Based on Changes in Intestinal Flora. Seminars in Cancer Biology, 70, 3-10. https://doi.org/10.1016/j.semcancer.2020.05.004 |
| [18] | Gilmore, W.J., Johnston, E.L., Bitto, N.J., et al. (2022) Bac-teroides fragilis Outer Membrane Vesicles Preferentially Activate Innate Immune Receptors Compared to Their Parent Bacteria. Frontiers in Immunology, 13, Article ID: 970725. https://doi.org/10.3389/fimmu.2022.970725 |
| [19] | Laurence, A., Tato, C.M., Davidson, T.S., et al. (2007) Interleu-kin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation. Immunity, 26, 371-381. https://doi.org/10.1016/j.immuni.2007.02.009 |
| [20] | Brockmann, L., Giannou, A., Gagliani, N., et al. (2017) Regula-tion of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis. International Journal of Molecular Sciences, 18, Article No. 1033.
https://doi.org/10.3390/ijms18051033 |
| [21] | Chung, L., Orberg, E.T., Geis, A.L., et al. (2018) Bacteroides fragilis Toxin Coordinates a Pro-Carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. Cell Host & Mi-crobe, 23, 203-214.e5.
https://doi.org/10.1016/j.chom.2018.02.004 |
| [22] | Wang, C., Li, P., Xuan, J., et al. (2017) Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation. Cellular Physiology and Biochemistry, 42, 729-742.
https://doi.org/10.1159/000477890 |
| [23] | Tariq, H., Noreen, Z., Ahmad, A., et al. (2022) Colibactin Possessing E. coli Isolates in Association with Colorectal Cancer and Their Genetic Diversity among Pakistani Population. PLOS ONE, 17, e0262662.
https://doi.org/10.1371/journal.pone.0262662 |
| [24] | Liu, S., Zhao, W., Lan, P., et al. (2021) The Microbiome in In-flammatory Bowel Diseases: From Pathogenesis to Therapy. Protein & Cell, 12, 331-345. https://doi.org/10.1007/s13238-020-00745-3 |
| [25] | Hernández-Luna, M.A., López-Briones, S. and Luria-Pérez, R. (2019) The Four Horsemen in Colon Cancer. Journal of Oncology, 2019, Article ID: 5636272. https://doi.org/10.1155/2019/5636272 |
| [26] | Veziant, J., Villéger, R., Barnich, N., et al. (2021) Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer. Cancers, 13, Article No. 2215. https://doi.org/10.3390/cancers13092215 |
| [27] | Cuevas-Ramos, G., Petit, C.R., Marcq, I., et al. (2010) Escherichia coli Induces DNA Damage in Vivo and Triggers Genomic Instability in Mammalian Cells. Proceedings of the National Academy of Sciences, 107, 11537-11542.
https://doi.org/10.1073/pnas.1001261107 |
| [28] | Wilson, M.R., Jiang, Y., Villalta, P.W., et al. (2019) The Human Gut Bacterial Genotoxin Colibactin Alkylates DNA. Science, 363, eaar7785. https://doi.org/10.1126/science.aar7785 |
| [29] | Cougnoux, A., Dalmasso, G., Martinez, R., et al. (2014) Bacterial Genotoxin Colibactin Promotes Colon Tumour Growth by Inducing a Senescence-Associated Secretory Phenotype. Gut, 63, 1932-1942.
https://doi.org/10.1136/gutjnl-2013-305257 |
| [30] | Xing, J., Liao, Y., Zhang, H., et al. (2022) Impacts f MicroRNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 804689.
https://doi.org/10.3389/fcimb.2022.804689 |
| [31] | Maddocks, O.D.K., Scanlon, K.M. and Donnenberg, M.S. (2013) An Escherichia coli Effector Protein Promotes Host Mutation via Depletion of DNA Mismatch Repair Proteins. MBio, 4, e00152-13.
https://doi.org/10.1128/mBio.00152-13 |
| [32] | Choi, H.J., Kim, J., Do, K.H., et al. (2013) Enteropathogenic Esche-richia coli-Induced Macrophage Inhibitory Cytokine 1 Mediates Cancer Cell Survival: An in Vitro Implication of Infec-tion-Linked Tumor Dissemination. Oncogene, 32, 4960-4969. https://doi.org/10.1038/onc.2012.508 |
